Literature DB >> 9223558

Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists.

D J Martin1, P Lluel, E Guillot, A Coste, D Jammes, I Angel.   

Abstract

We investigated the relevance of selectivity for a given alpha-1-adrenoceptor subtype for in vivo uroselectivity of several alpha-1-adrenoceptor antagonists (alfuzosin, doxazosin, prazosin, tamsulosin, terazosin and 5-Me-urapidil). Comparison of the affinities of these alpha-1-adrenoceptor antagonists at the cloned alpha-1a, alpha-1b and alpha-1d-adrenoceptor subtypes revealed that tamsulosin and 5-Me-urapidil showed selectivity for the alpha-1a subtype. No significant correlations were found between the affinities for alpha-1b or alpha-1d-adrenoceptors and the pK(B) values obtained against phenylephrine-induced contraction of the rabbit prostate in vitro. In contrast, the antagonist potencies in rabbit prostate were correlated (r = 0.89, P < .05) with the pKi values for the alpha-1a-adrenoceptor subtype. However, the pK(B) values were consistently smaller (by 0.6 to 1.9 log unit) than the pKi values for the alpha-1a-adrenoceptor subtype, a result that suggests that the alpha-1-adrenoceptor mediating urethral contractions does not have all the characteristics of the alpha-1a-adrenoceptor. The simultaneous measurement of urethral and arterial pressures in the same conscious male rat allows evaluation of the functional uroselectivity of these antagonists based on their respective effects on both pressures. Dose ranges were selected according to effects on urethral pressure and most antagonists were found effective within the 3 to 100 microg/kg i.v. range. Alfuzosin markedly decreased urethral pressure and either did not decrease blood pressure (10-30 microg/kg) or slightly decreased it at the highest dose tested (100 microg/kg). Doxazosin did not produce sustained reductions in urethral pressure until a dose of 30 microg/kg. Blood pressure was not reduced until 100 microg/kg. Prazosin reduced urethral pressure and blood pressure within the same dose-range whereas terazosin did not decrease urethral pressure at doses that significantly decreased blood pressure (30 and 100 microg/kg). 5-Me-urapidil, an alpha-1a-selective compound did not significantly modify urethral and blood pressure whereas tamsulosin, another alpha-1a-selective compound reduced urethral pressure and blood pressure within the same dose range. In conclusion, in the conscious male rat the functional uroselectivity is not correlated with a selective affinity for the alpha-1a-adrenoceptor subtype.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223558

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.

Authors:  Y Homma; K Hamada; Y Nakayama; G Tsujimoto; K Kawabe
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

2.  Efficacy of silodosin in the treatment of distal ureteral stones 4 to 10 mm in diameter.

Authors:  Mustafa Yuksel; Serdar Yilmaz; Husnu Tokgoz; Soner Yalcinkaya; Serkan Baş; Tümay Ipekci; Ali Yildiz; Nihat Ates; Murat Savas
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  The role of alpha(1)-adrenoceptors and 5-HT(1A) receptors in the control of the micturition reflex in male anaesthetized rats.

Authors:  R K Conley; T J Williams; A P Ford; A G Ramage
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

4.  The effects of two systemic alpha1-adrenergic blockers on pupil diameter: a prospective randomized single-blind study.

Authors:  Rana Altan-Yaycioglu; Ozgur Yaycioglu; Umit Gul; Aysel Pelit; Fatih M Adibelli; Yonca A Akova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-03-16       Impact factor: 3.000

5.  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells.

Authors:  Dorathy-Ann Harris; Ji-Min Park; Kyung-Soon Lee; Cong Xu; Nephi Stella; Chris Hague
Journal:  J Pharmacol Exp Ther       Date:  2017-02-14       Impact factor: 4.030

Review 6.  α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.

Authors:  Shizuo Yamada; Yoshihiko Ito; Hideo Tsukada
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

7.  Tamsulosin shows a higher unbound drug fraction in human prostate than in plasma: a basis for uroselectivity?

Authors:  Cees Korstanje; Walter Krauwinkel; Francisca L C van Doesum-Wolters
Journal:  Br J Clin Pharmacol       Date:  2011-08       Impact factor: 4.335

Review 8.  Is Tamsulosin Linked to Dementia in the Elderly?

Authors:  Jason K Frankel; Yinghui Duan; Peter C Albertsen
Journal:  Curr Urol Rep       Date:  2018-07-03       Impact factor: 3.092

Review 9.  Alfuzosin: a review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia.

Authors:  Kate McKeage; Greg L Plosker
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 10.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.